Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hsu

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Developmental Cell|February 8, 2022
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticityPreetish Kadur Lakshminarasimha Murthy, Rui Xi, Diana Arguijo, et al.
Annals of Surgical Oncology|August 12, 2020
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver MetastasesJohn M Creasy, Kyle J Napier, Sarah A Reed, et al.
Annals of Surgical Oncology|May 15, 2023
Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract CancersKristen E Rhodin, Annie Liu, Alex Bartholomew, et al.
The Ocular Surface|December 12, 2025
Prevalence of novel Sjögren's antibodies in a multi-center cohort of dry eye patientsDavid Hsu, Yinxi Yu, Esen K Akpek, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
The Journal of Clinical Investigation|February 5, 2020
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapyBalamayoora Theivanthiran, Kathy S Evans, Nicholas C DeVito, et al.
Annals of Surgical Oncology|July 9, 2025
Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial InfusionAnnie Liu, Ellery H Reason, Brittany G Sullivan, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Optimizing the production of suspension cells using the G-Rex "M" seriesPradip Bajgain, Roopa Mucharla, John Wilson, et al.
Frontiers in Oncology|March 3, 2020
From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision MedicineSneha R Rao, Jason A Somarelli, Erdem Altunel, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Developmental Cell|February 8, 2022
Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticityPreetish Kadur Lakshminarasimha Murthy, Rui Xi, Diana Arguijo, et al.
Annals of Surgical Oncology|August 12, 2020
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver MetastasesJohn M Creasy, Kyle J Napier, Sarah A Reed, et al.
Annals of Surgical Oncology|May 15, 2023
Trends in Receipt of Adjuvant Chemotherapy and its Impact on Survival in Resected Biliary Tract CancersKristen E Rhodin, Annie Liu, Alex Bartholomew, et al.
The Ocular Surface|December 12, 2025
Prevalence of novel Sjögren's antibodies in a multi-center cohort of dry eye patientsDavid Hsu, Yinxi Yu, Esen K Akpek, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2008
A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Retraction for Garman et al: A genomic approach to colon cancer risk stratification yields biologic insights into therapeutic opportunitiesKatherine S Garman, Chaitanya R Acharya, Elena Edelman, et al.
The Journal of Clinical Investigation|February 5, 2020
A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti-PD-1 immunotherapyBalamayoora Theivanthiran, Kathy S Evans, Nicholas C DeVito, et al.
Annals of Surgical Oncology|July 9, 2025
Circulating Tumor DNA as a Novel Prognostic Biomarker of Therapeutic Efficacy in Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial InfusionAnnie Liu, Ellery H Reason, Brittany G Sullivan, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Optimizing the production of suspension cells using the G-Rex "M" seriesPradip Bajgain, Roopa Mucharla, John Wilson, et al.
Frontiers in Oncology|March 3, 2020
From the Clinic to the Bench and Back Again in One Dog Year: How a Cross-Species Pipeline to Identify New Treatments for Sarcoma Illuminates the Path Forward in Precision MedicineSneha R Rao, Jason A Somarelli, Erdem Altunel, et al.
Pageof 14